Agf Investments Inc. Eli Lilly & CO Transaction History

Agf Investments Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $816,486 - $1.01 Million	-3,479 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $255,654 - $317,268	1,137 Added 48.55%	3,479 $961,000
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $304,035 - $374,158	1,372 Added 141.44%	2,342 $541,000
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $189,577 - $245,217	-1,050 Reduced 51.98%	970 $223,000
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $104,507 - $135,289	636 Added 45.95%	2,020 $377,000
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $143,375 - $189,720	-1,099 Reduced 44.26%	1,384 $234,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $71,647 - $82,873	490 Added 24.59%	2,483 $368,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $31,240 - $37,597	-229 Reduced 10.31%	1,993 $327,000
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $264,529 - $327,411	2,222 New	2,222 $308,000

4,267

757M

10.2M

11.4M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $837B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.